ArticleFrontiers in psychiatry2025
Case Report: Electroacupuncture combined with transcutaneous auricular vagus nerve stimulation for treating antiseizure medication-resistant juvenile myoclonic epilepsy.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Juvenile myoclonic epilepsy as a spectrum disorder: mechanisms of drug resistance and precision management.Frontiers in neurologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with juvenile myoclonic epilepsy (JME) are frequently resistant to antiseizure medication (ASM) and can have a significantly impaired quality of life (QOL). This case report examines successful treatment of JME using a combination of electroacupuncture and transcutaneous auricular vagus nerve stimulation (taVNS). Case presentation: A 19-year-old Japanese male with a 5-year history of ASM-resistant JME presented with frequent myoclonic and generalized tonic-clonic seizures, daily premonitory auras, and psychological distress. Despite treatment with sodium valproate and clonazepam, he continued to experience multiple seizures weekly and was unable to attend school due to anxiety. After declining surgical vagus nerve stimulation, he sought acupuncture treatment. Weekly sessions of electroacupuncture (ST36 and LR3) and taVNS targeting the left auricular concha were initiated. From the second session, electroacupuncture was intensified at GV20, GV24, and GB18 due to initial symptom worsening. Results: Over the course of eight sessions, seizure frequency decreased from multiple daily episodes to a single seizure in the final 4 weeks. Premonitory auras and mild-to-moderate seizures also declined significantly. SF-36 assessments at baseline, 1 month, and 2 months revealed improvements across all subscales except physical functioning, with scores for bodily pain, vitality, and social functioning exceeding national norms at the final assessment. Component summary scores for physical, mental, and role/social functioning also improved consistently. The patient resumed school attendance, experienced reduced anxiety regarding seizures, and reported enhanced social engagement. Conclusion: This case suggests that combined electroacupuncture and taVNS may be a promising non-pharmacological adjunct in the treatment of ASM-resistant JME, contributing to improved seizure control and multidimensional QOL outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.